Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy

NCT ID: NCT07218237

Last Updated: 2025-10-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-03-31

Study Completion Date

2028-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The MINDBP study will enroll 90 pregnant women at risk for HDP across two sites (MCW and Brown) and randomize them to: (1) mindfulness training (MT) plus wearable biosensors, (2) MT alone, or (3) routine prenatal care. MT participants will receive 8 weekly phone-based MT sessions plus two booster sessions at 1 and 2 months post-intervention. The primary outcome is study feasibility.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The MINDBP study will enroll 90 pregnant women at risk for HDP across two sites (MCW and Brown) and randomize them to: (1) MT + wearable biosensors, (2) MT alone, or (3) routine prenatal care. MT participants will receive 8 weekly phone-based MT sessions plus two booster sessions at 1 and 2 months post-intervention. All participants will wear Garmin Vivoactive 4 watches. Blood pressure, heart rate, heart rate variability, perceived stress, and pregnancy-related anxiety will be assessed at baseline (≤16 weeks), post-intervention (\~24 weeks), and after each booster (\~28 and 32 weeks). Feasibility, fidelity, and acceptability outcomes will be assessed after each post-intervention

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preeclampsia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants
All participants will wear a Garmin Vivoactive 4 biosensor watch throughout the study. However, only one of the arms will have real-time access to thier data, while the other 2 arms will be masked to their watch data. The study team will have access to the watch data for all 3 arms.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MT + Biofeedback

Mindfulness training plus self-monitoring with access to data from wearable biosensor

Group Type EXPERIMENTAL

Mindfulness training

Intervention Type BEHAVIORAL

Mindfulness training with trained instructors

Garmin Vivoactive 4 watch

Intervention Type BEHAVIORAL

Biofeedback with a wearable biosensor that continuously monitors heart rate variability and generates stress scores.

MT

Mindfulness training (no access to wearable biosensor data)

Group Type EXPERIMENTAL

Mindfulness training

Intervention Type BEHAVIORAL

Mindfulness training with trained instructors

Control

Routine prenatal care alone

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mindfulness training

Mindfulness training with trained instructors

Intervention Type BEHAVIORAL

Garmin Vivoactive 4 watch

Biofeedback with a wearable biosensor that continuously monitors heart rate variability and generates stress scores.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant patients at gestational age \<= 16 weeks
* Live, non-anomalous gestation
* Normotensive at enrollment
* Meet criteria consistent with 'moderate' to 'high' risk for preeclampsia based on ACOG/USPSTF guidelines for low-dose aspirin administration to prevent hypertensive disorders of pregnancy

Exclusion Criteria

* Multiple gestation
* Chronic (pregestational hypertension)
* Inability of unwillingness to provide informed consent
* Active suicidality or psychosis
* Ongoing mind-body practice (e.g., yoga, meditation, mindfulness \>= once per week)
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical College of Wisconsin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Anna Palatnik, MD

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anna Palatnik, MD

Role: PRINCIPAL_INVESTIGATOR

Medical College of Wisconsin

Margaret Bublitz, PhD

Role: PRINCIPAL_INVESTIGATOR

Brown University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Brown University

Providence, Rhode Island, United States

Site Status

Medical College of Wisconsin

Milwaukee, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Anna Palatnik, MD

Role: CONTACT

14148056627

Alyssa Hernandez, DO

Role: CONTACT

4149552781

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Margaret Bublitz, PhD

Role: primary

401-793-7884

Anna Palatnik, MD

Role: primary

14148056627

Alyssa Hernandez, DO

Role: backup

4149552781

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PRO00056473

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sleep Health in Pregnant Women in ENRICH
NCT07216287 NOT_YET_RECRUITING
CNAP™ Monitor Study
NCT01356082 COMPLETED
Maternal Non-Stress Testing
NCT04343482 COMPLETED